Study for Optimizing Anti-inflammatory Prophylaxis

Clinical trial NCT03383328 · COMPLETED

Trial details

NCT number: NCT03383328
Sponsor: Line Kessel
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Postoperative Cystoid Macular Edema Irvine-Gass Syndrome

Start date: 2018-02-01
Primary completion: 2019-12-18
Enrollment: 470

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.